Saleha Sajid, MD

Saleha Sajid, MD, treats cancer and blood disorders as a Board-Certified Medical Oncologist.  Dr. Sajid excels at providing compassionate high-quality care to individuals with a focus on personalized treatment, evidence-based medicine, and care coordination.

Dr. Sajid works as part of a multidisciplinary team of surgical oncologists, radiation oncologists, reconstructive surgeons, and clinical trial investigators to deliver cutting-edge, safe, well-coordinated, and supportive care to people with cancer and their families.

Dr. Sajid identifies the best treatments available in oncology with evidence-based alternative treatments for symptom control. In addition, she has in-depth training in Geriatrics to offer tailored cancer care in elderly individuals. This means balancing the benefit of chemotherapy while minimizing side effects in older and vulnerable patients.

Education

Dr. Sajid obtained her medical degree from DOW Medical University of Health Sciences and completed her Internal Medicine Residency at Illinois Masonic Medical Center. She then proceeded to obtain her Fellowship in Geriatrics and Hematology/Oncology at the University of Chicago Medical Center.

Medical Interests

Dr. Sajid achieved the prestigious Young Investigator Award during her Oncology Fellowship at The University of Chicago. She actively works as a Principal Investigator on cutting-edge clinical trials to offer promising new treatments. She enjoys a supportive relationship with pharmaceutical companies to provide evidence-based clinical trial options to everyone that she sees without regard to social status or means.

Family

Dr. Sajid is married with two young children. She enjoys an active lifestyle with her family which includes hiking, exercising, and cooking nutritious and delicious food.

Publications:

Original Peer-Reviewed Articles

-Bylow K, Hemmerich J, Mohile S, MD, Stadler W, Sajid S, Dale W. Frailty, physical performance, obesity and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study. Urology; 2011 Jan 24.

-Sajid S, Mohile SG, Szmulewitz R, Posadas E, Dale W. Individualized decision making for older men with prostate cancer: balancing cancer control with treatment consequences. Seminars in Oncology, 2011 Apr;38(2):309-25.

-Mahmood S, R. Martinez de Llano S and Sajid S. False positive FDG-PET extensive diffuse abdominal tracer activity in a patient with CLL on whole-body (18)FDG-PET/CT indicative of Ritcher’s transformation. Nuklearmedizin, 2009; 48(6): N69-N70.

-Sajid S, Kotwal A, Dale W. Interventions to reduce racial and ethnic disparities in prostate cancer screening, diagnosis, and treatment: A systematic review. Journal of General Internal Medicine, 2012; 27(8):1068-78.

-Sajid S, Jakubowiak A, Dale W. Multiple Myeloma in Older Adults. Current Geriatrics Reports, 2014 3(3)200-208.

-Sajid S, Dale W, Mustian K, Mohile S. Novel Physical Activity Interventions for Older Prostate Cancer Patients. Journal of Geriatric Oncology, 2016; 7(2): 71-80

Peer-reviewed works in ‘non-traditional’ outlets-D’Amico A, Alibhai S, Dale W and Sajid S. Management of prostate cancer in older adults: To treat or not to treat. Published in ASCO 2011 Educational Booklet.

Editorials, Reviews, Book Chapters

-Mahmood S, Sajid S. 2012. Chapter 74. Recist and WHO Criteria; MR and CT perfusion and pharmacokinetic imaging; clinical applications and theory